In this context, we found a positive correlation between the elevated percentage of CCR6+ Th populations and ESR in anti-DNA+ SLE patients, thereby supporting the notion that these cells indeed may play a critical role in disease activity specifically, in anti-DNA+ SLE patients. The gene discussed is CCR6; the disease is systemic lupus erythematosus.